Please join our excellent speakers who will discuss a range of topics related to the drug development and clinical trial process. From the underlying translational science to phase I trial design and beyond, to the incorporation of genomics and precision medicine in trials and in practice.

For enquiries, please contact Sathya Manoharan,  Early Drug Development Fellow (PeterMac 2022/23) on [email protected]

Date Topic Summary
26th July 2023 Phase I Trial Design

Jayesh Desai and Ben Tran

Broad Overview of the Program

Introduction to Drug Development

Drug development trial design in 2023

Pharmacology/PD basics and applied sciences

30th Aug 2023 Kinase inhibition/targeting kinases: what makes a good oncogenic target?

Grant McArthur and Stephen Luen

Genomics in drug development / clinical practice

Kinase inhibitors vs cytotoxics vs IO from a drug development perspective

4th October 2023 (rescheduled) Cancer Immunology: Part 1

Paul Neeson and Stephen Luen

Underlying science

Potential targets/agents

TBA Cancer Immunology: Part 2

Paul Neeson and Stephen Luen

Complex biomarkers
8th Nov 2023 Overview of CAR-T and BiTEs

Mark Dowling

Overview of CAR-T and BiTE drug therapies

Toxicity management

23rd Nov 2023 Intro to Genomics

Kortnye Smith

Basic principles of genomic testing options

Benefits/indications of each

Effect of the results, issues/challenges

Case reports